Polydatin-containing composition and application thereof

The technology of polydipside and composition is applied in the field of compositions containing polydipside, which can solve the problems of no further description of the feasible preparation method of the solution, limited solubility, difficulty in reaching the drug concentration in conventional aqueous solutions, etc., and achieves good water solubility, low toxicity, Response to the effect of changing the temperature range

Active Publication Date: 2021-09-03
HUNAN NUSTREETCARAX
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Chinese patent application CN1709269A points out: in the research literature of polydatin basic pharmacology, in human experiment research, adopt intravenous route to give polydatin more, test sample adopts water or physiological saline to prepare polydatin solution of 2-5mg / mL concentration more, but literature There is no further explanation on the feasible preparation method of the solution; according to literature calculations, the clinical effective dose of polydatin (for adults) should be above 112mg / time, and under the specifications of 1-20mL conventional injections, the concentration of polydatin in clinical injections should not be lower than 5.6mg / mL; the solubility of polydatin in pure water or normal saline solution is limited, and its conventional aqueous solution is difficult to reach the drug concentration described in the literature: at room temperature, the saturation concentration of polydatin in water and normal saline is lower than 0.5 mg / mL, much lower than the above-mentioned 2-5mg / mL administration concentration
It can be seen that ethanol and / or propylene glycol are used as organic solvents in this patent to increase the solubility of polydatin, and the formed composition contains a large amount of organic solvents, which limits the application of polydatin to a certain extent, and can only be injected with water or physiologically. Saline can be used in human body only after being diluted to a certain extent

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polydatin-containing composition and application thereof
  • Polydatin-containing composition and application thereof
  • Polydatin-containing composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Composite hydrogels are made through the following steps:

[0029] Step 1, add 30wt% sodium hydroxide aqueous solution in chitosan, after stirring at 300r / min for 45min, the mixture is placed in a freezer, frozen at -23°C for 20h, then the frozen mixture is taken out, and placed in Thaw in the oven, then put the thawed mixture back into the three-necked flask, add isopropanol, stir at 300r / min for 30min, then add the isopropanol solution of chloroacetic acid drop by drop to keep the temperature of the reaction system below 8°C , after the dropwise addition, continue to react for 20h, then filter the reaction mixture, wash the filter cake with deionized water, centrifuge, take the filter cake, then fully dialyze with deionized water, freeze-dry the dialyzate, and obtain carboxymethyl Base chitosan, wherein, the amount ratio of chitosan, 30% sodium hydroxide aqueous solution, isopropanol, chloroacetic acid isopropanol solution is 1g: 4mL: 10mL: 4g, and in the isopropanol ...

Embodiment 2

[0032] Composite hydrogel is made through the following steps: with reference to each step in embodiment 1; In step one, the consumption ratio of the isopropanol solution of chitosan, 30% sodium hydroxide aqueous solution, isopropanol, chloroacetic acid is 1g: 6mL: 15mL: 5g, and the mass fraction of chloroacetic acid in the isopropanol solution of chloroacetic acid is 45%; in step 2, silk fibroin, poloxamer, deionized water, p-toluenesulfonic acid, carboxymethyl shell The dosage ratio of the polysan aqueous solution is 12mg: 100mg: 10mL: 2.5mL: 60mg, and the mass fraction of the carboxymethyl chitosan aqueous solution is 40%, and the poloxamer is P407.

Embodiment 3

[0041] A composition containing polydatin, each raw material is weighed according to the formula in Table 1:

[0042] Table 1

[0043] raw material Dosage The ethanol solution of polydatin (mass concentration is 60%) 0.5g Composite hydrogel is prepared for embodiment 1 2g normal saline 10mL Sodium carbonate-sodium bicarbonate buffer solution Adjust the pH of the solution to 8.0

[0044] Preparation method: Use physiological saline as a solvent, immerse the composite hydrogel in the solvent, add polydatin ethanol solution, add sodium carbonate-sodium bicarbonate buffer solution, stir at 200r / min for 20min at 37°C, and then place in Stand at constant temperature in a fume hood for 12 hours, remove absolute ethanol, and obtain a polydatin composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a polydatin-containing composition and application thereof, belongs to the technical field of polydatin application, and aims to solve the technical problem that the solubility of polydatin in pure water or a normal saline solution is limited. The polydatin-containing composition adopts composite hydrogel as a drug carrying agent, so that the solubility of polydatin in an aqueous solution or the normal saline solution is improved, and the polydatin-containing composition meets the clinical medication requirements of polydatin; and according to the composite hydrogel, the reverse reversible thermal gelling property of poloxamer is utilized, silk fibroin and carboxymethyl chitosan are introduced, carboxyl on the carboxymethyl chitosan reacts with amino on the silk fibroin and hydroxyl on the poloxamer at the same time, an interpenetrating network is formed in a composite gel system, the mechanical strength of the composite hydrogel is improved, and hydrophilic chain segments of the silk fibroin and the poloxamer exist in the whole gel system, so that the gel-sol transition temperature tends to body temperature, and the composite hydrogel is suitable for human body administration.

Description

technical field [0001] The invention belongs to the technical field of polydatin application, and in particular relates to a composition containing polydatin and its application. Background technique [0002] Polydatin, namely 3,4', 5-trihydroxystilbene-3-β-D-glucoside (C20H22O8) as a medicinal ingredient can be found in literature and patent reports. Circulation, hypolipidemic, anti-tumor and other pharmacological activities. [0003] Chinese patent application CN1709269A points out: in the research literature of polydatin basic pharmacology, in human experiment research, adopt intravenous route to give polydatin more, test sample adopts water or physiological saline to prepare polydatin solution of 2-5mg / mL concentration more, but literature There is no further explanation on the feasible preparation method of the solution; according to literature calculations, the clinical effective dose of polydatin (for adults) should be above 112mg / time, and under the specifications o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K9/70A61K31/7034A61K47/26A61K47/36A61K47/42A61K47/20A61P17/02A61P17/16
CPCA61K31/7034A61K9/06A61K47/36A61K47/42A61K47/26A61K9/0019A61K9/0014A61K9/7015A61P17/02A61P17/16A61K47/20
Inventor 张建张宝堂谭家忠尹振华王会文
Owner HUNAN NUSTREETCARAX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap